What you need to know about the 'alarming' new XBB.1.5 COVID subvariant


A new COVID-19 Omicron subvariant is causing concern among scientists monitoring the virus's spread and evolution, CNN reports. On Friday, the Centers for Disease Control and Prevention's COVID-19 variant dashboard revealed startling data concerning a variant with features that could encourage a surge of COVID cases in the U.S. — XBB.1.5.
Throughout December, the CDC estimates that XBB.1.5 has more than doubled its share of positive COVID cases every week, leading it to rise from 4 percent to 41 percent of new infections by the end of the month. XBB.1.5 is responsible for 75 percent of new cases in the Northeast, per the CDC. Virologists and epidemiologists predict that the features of this Omicron variant could drive a surge of positive cases in the U.S. However, according to CNN, it remains to be seen how extensive or severe that wave could be.
Despite lingering concerns that China's ongoing surge following the unraveling of its zero COVID policy would pose a threat, experts say XBB.1.5 emerged in the U.S. According to GISAID, a global initiative to catalog and track variants of COVID, the subvariant was first detected in New York and Connecticut in late October. It's the product of two descendants of BA.2, the subvariant that drove a small surge in the U.S. in April.
The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.

Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
A recent study found that the XBB sublineage had higher levels of immune evasion, making it exponentially less likely to be neutralized by antibodies in previously infected or vaccinated people. Scientists behind the study called the level of immune evasion "alarming," suggesting that it could be detrimental to the efficacy of COVID vaccines.
XBB.1.5 also has a genetic mutation that allows it to bind more tightly to ACE2, the entryway for viruses into human cells, meaning it is more infectious.
"The mutation is clearly letting XBB.1.5 spread better," Jesse Bloom, a computational virologist at the Fred Hutchinson Cancer Center who flagged the mutation, wrote in an email to CNN.
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Theara Coleman has worked as a staff writer at The Week since September 2022. She frequently writes about technology, education, literature and general news. She was previously a contributing writer and assistant editor at Honeysuckle Magazine, where she covered racial politics and cannabis industry news.
-
One great cookbook: ‘The Woks of Life’
The Week Recommends A family’s opinionated, reliable take on all kinds of Chinese cooking
-
Digital addiction: the compulsion to stay online
In depth What it is and how to stop it
-
Can Trump bully Netanyahu into Gaza peace?
Today's Big Question The Israeli leader was ‘strong-armed’ into new peace deal
-
FDA OKs generic abortion pill, riling the right
Speed Read The drug in question is a generic version of mifepristone, used to carry out two-thirds of US abortions
-
The new Stratus Covid strain – and why it’s on the rise
The Explainer ‘No evidence’ new variant is more dangerous or that vaccines won’t work against it, say UK health experts
-
RFK Jr. vaccine panel advises restricting MMRV shot
Speed Read The committee voted to restrict access to a childhood vaccine against chickenpox
-
Texas declares end to measles outbreak
Speed Read The vaccine-preventable disease is still spreading in neighboring states, Mexico and Canada
-
RFK Jr. shuts down mRNA vaccine funding at agency
Speed Read The decision canceled or modified 22 projects, primarily for work on vaccines and therapeutics for respiratory viruses
-
Measles cases surge to 33-year high
Speed Read The infection was declared eliminated from the US in 2000 but has seen a resurgence amid vaccine hesitancy
-
Kennedy's vaccine panel signals skepticism, change
Speed Read RFK Jr.'s new vaccine advisory board intends to make changes to the decades-old US immunization system
-
Kennedy ousts entire CDC vaccine advisory panel
speed read Health Secretary RFK Jr. is a longtime anti-vaccine activist who has criticized the panel of experts